-+ 0.00%
-+ 0.00%
-+ 0.00%

On August 31, according to Huadong Pharmaceutical, recently, Hangzhou Sino-US Huadong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Huadong Pharmaceutical Co., Ltd., and its strategic partner Heidelberg Pharma Research GmbH, a wholly-owned subsidiary of Heidelberg Pharma AG, officially signed a new additional cooperation agreement. The two sides will focus on joint research and development of next-generation antibody drug conjugates and push the strategic partnership into a new stage.

Zhitongcaijing·08/31/2026 08:49:04
Listen to the news
On August 31, according to Huadong Pharmaceutical, recently, Hangzhou Sino-US Huadong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Huadong Pharmaceutical Co., Ltd., and its strategic partner Heidelberg Pharma Research GmbH, a wholly-owned subsidiary of Heidelberg Pharma AG, officially signed a new additional cooperation agreement. The two sides will focus on joint research and development of next-generation antibody drug conjugates and push the strategic partnership into a new stage.